What Future Holds for Dengue Vaccine Market: Top Players to Be Benefited: Biological E. Limited, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Merck & Co.
Burdening occurrence of dengue fever across the Asia-Pacific region has prompted the demand for effective vaccines and medications to supress this viral malaise. While several pharmaceutical companies are striving to develop a cure for dengue, the fever's incidence rate in Asia-Pacific is rising at an alarming rate. A recent report published by Future Market Insights predicts that in 2017, an estimated 70.3% of global dengue vaccines market will be dominated by Asia-Pacific. Through 2027, the region will continue to be...
View full press release